跳至主要内容
临床试验/NCT04002219
NCT04002219已完成不适用

Efficacy Evaluation of the Mushroom Beverage on Emotion Regulation

National Science and Technology Council, Taiwan2 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2019年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
80
试验地点
2
主要终点
Change of objective depressive symptoms

研究概览

简要总结

Major Depression Disorder is one of the most common psychiatric disease and has affecting approximately 350 million people in the world. According to World Health Organization's report, it may be the first burden of disease in 2030. Due to the high morbidity and low acceptance in the treatment, it is necessary to find some nature compounds to prevent the disease.

Cordyceps militaris, one of the most treasure Chinese herbs in Asia, contains many kinds of component such as cordycepin, polysaccharide, mannitol. In winter, it appears as an worm in the soil, afterwards, it grows out of the soil and convert into grass in summer. A previous study has demonstrated that Cordyceps militaris has anti-depressive effect in mouse tail suspension test, and in this study we will explore its effect in human subjects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 21 -items Hamilton Rating Scale for Depression scores 8-17 points upon interview
  • At least 2 weeks not taking antidepressants, antipsychotics or antiepileptics.
  • Understand the whole process of the study and had signed the informed consent form

排除标准

  • Had been diagnosed with severe mental disorder, schizophrenia, bipolar disorder, personality disorder, substance use disorder or alcohol use disorder, or other severe physical illness that is not expected to survive during the intervention period.
  • Currently taking antidepressants or other medication that may impact the study.
  • Expected to be non-adherent.
  • Without sufficient data to confirm safety.
  • Pregnant woman
  • Allergic to fungal products.
  • Currently taking MAO-inhibitors

结局指标

主要结局

Change of objective depressive symptoms

时间窗: 8 weeks

Measured by Hamilton Rating Scale for Depression

Change of subjective depressive symptoms

时间窗: 8 weeks

Measured by Beck Depression Inventory-II

Change of somatic symptoms

时间窗: 8 weeks

Measured by Neurotoxicity Rating Scale, a 39-item self-report scale to evaluate the somatic symptoms such as anorexia, fatigue and pain; higher scores indicate higher severity.

Cortisol level

时间窗: 8 weeks

Measured as a stress-related biomarker

次要结局

未报告次要终点

研究者

发起方
National Science and Technology Council, Taiwan
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Kuan-Pin

Principal Investigator

National Science and Technology Council, Taiwan

研究点 (2)

Loading locations...

相似试验

Efficacy Evaluation of the Mushroom Beverage on... | 临床试验